To elucidate whether polymorphisms of C2, C3, and CFB genes are major genetic determinants of age-related macular degeneration (AMD) in a Greek population.
Methods
This was a case-control association study comprising 120 Greek patients with early and late-stage AMD and 140 independent controls of Caucasian origin. All participants were genotyped for rs547154, rs2230199, rs641153, and rs12614 polymorphisms by a combination of PCR and direct DNA sequencing assays.
Results
The frequency of the rs2230199 G allele (minor allele) was significantly higher in patients with AMD in comparison with controls (0.34 vs 0.22, p = 0.0031) and similar to the frequency of other reported populations. There was a significant difference in the frequencies of the rs2230199 genotypes among cases and controls (p = 0.0055). rs2230199 was found to be a significant predictor of advanced AMD status (odds ratio 6.41, confidence interval [CI] 2.72-15.09, p<0.0001; area under the curve 0.706, CI 0.61-0.78, p<0.0001]). For the other single nucleotide polymorphism (SNP) loci, the allele and genotype frequencies did not reach statistical significance. The minor allele frequencies in controls and cases were similar and still much lower than the frequencies reported in other populations.
Conclusions
The rs547154, rs641153, and rs12614 SNPs were not associated with AMD development in Greek patients. However, this finding should be viewed with caution as the particular polymorphisms presented with very low frequencies in the Greek population. Finally, the replication of the reported associations of C3 with AMD suggests that the presence of the C3 G allele could serve as a high-risk genetic marker for the development of AMD and the progression of the disease to the advanced clinical stage.
de JongPTAge-related macular degeneration. N Engl J Me20063551474–85
2.
FriedmanDSO'ColmainBJMuñozBEye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmo2004122564–72
3.
DingXPatelMChanCCMolecular pathology of age-related macular degeneration. Prog Retin Eye Re2009281–18
4.
JagerRDMielerWFMillerJWAge-related macular degeneration. N Engl J Me20083582606–17
5.
SwaroopAChewEYRickmanCBAbecasisGRUnraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Gene20091019–43
6.
HaddadSChenCASantangeloSLSeddonJMThe genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmo200651316–63
7.
HagemanGSLuthertPJVictor ChongNHJohnsonLVAndersonDHMullinsRFAn integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Re200120705–32
8.
CrabbJWMiyagiMGuXDrusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci US20029914682–7
9.
SchollHPCharbel IssaPWalierMSystemic complement activation in age-related macular degeneration. PLoS On20083e2593
10.
EdwardsAORitterRAbelKJManningAPanhuysenCFarrerLAComplement factor H polymorphism and age-related macular degeneration. Scienc2005308421–4
11.
KleinRJZeissCChewEYComplement factor H polymorphism in age-related macular degeneration. Scienc2005308385–9
12.
HagemanGSAndersonDHJohnsonLVA common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci US20051027227–32
13.
GoldBMerriamJEZernantJAMD Genetics Clinical Study Group. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Gene200638458–62
14.
YatesJRSeppTMatharuBKGenetic Factors in AMD Study GroupComplement C3 variant and the risk of age-related macular degeneration. N Engl J Me2007357553–61
15.
MallerJBFagernessJAReynoldsRCNealeBMDalyMJSeddonJMVariation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Gene2007391200–1
16.
RiveraAFisherSAFritscheLGHypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Gene2005143227–36
17.
DesprietDDKlaverCCWittemanJCComplement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAM2006296301–9
18.
DesprietDDvan DuijnCMOostraBAComplement component C3 and risk of age-related macular degeneration. Ophthalmolog2009116474–80
19.
BirdACBresslerNMBresslerSBThe International ARM Epidemiological Study GroupAn international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmo199539367–74
20.
BarrettJCFryBMallerJDalyMJHaploview: analysis and visualization of LD and haplotype maps. Bioinformatic200521263–5
21.
MarioliDIPharmakakisNDeliAHavvasIZarkadisIKComplement factor H and LOC387715 gene polymorphisms in a Greek population with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmo20092471547–53
22.
SilveiraACMorrisonMAJiFConvergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach. Vision Re201050698–715
23.
MorrisonMASilveiraACHuynhNSystems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomic20115538–68
24.
JunGNicolaouMMorrisonMAInfluence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology. PLoS On20116e25775
25.
FritscheLGChenWSchuMSeven new loci associated with age-related macular degeneration. Nat Gene201345433–9
FrancisPJHamonSCOttJWeleberRGKleinMLPolymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. J Med Gene200946300–7
28.
ArakawaSTakahashiAAshikawaKGenome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nat Gene2011431001–4
29.
ThakkinstianAMcKayGJMcEvoyMSystematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemio20111731365–79
30.
LiuXZhaoPTangSAssociation study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population. Retin2010301177–84
31.
RambausekMvan den Wall BakeAWSchumacher-AchRGenetic polymorphism of C3 and Bf in IgA nephropathy. Nephrol Dial Transplan19872208–11
32.
FinnJEZhangLAgrawalSJayneDROliveiraDBMathiesonPWMolecular analysis of C3 allotypes in patients with systemic vasculitis. Nephrol Dial Transplan199491564–7
33.
AppelGBCookHTHagemanGMembranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephro2005161392–403
34.
ParkKHFridleyBLRyuETosakulwongNEdwardsAOComplement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration. Invest Ophthalmol Vis Sc2009503386–93
35.
SpencerKLHauserMAOlsonLMProtective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Gene2007161986–92
36.
RichardsonAJIslamFMGuymerRHBairdPNAnalysis of rare variants in the complement component 2 (C2) and factor B (BF) genes refine association for age-related macular degeneration (AMD). Invest Ophthalmol Vis Sc200950540–3
37.
KaurIKattaSReddyRKThe involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration. Invest Ophthalmol Vis Sc20105159–63
38.
FarwickADaschBWeberBHPauleikhoffDStollMHenseHWVariations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study. Ey2009232238–44
39.
KimSJLeeSJKimNRChinHSAssociation of polymorphisms in C2, CFB and C3 with exudative age-related macular degeneration in a Korean population. Exp Eye Re20129642–7
40.
SundaresanPVashistPRavindranRDPolymorphisms in ARMS2/HTRA1 and complement genes and age-related macular degeneration in India: findings from the INDEYE study. Invest Ophthalmol Vis Sc2012537492–7
41.
NakataIYamashiroKYamadaRSignificance of C2/CFB variants in age-related macular degeneration and polypoidal choroidal vasculopathy in a Japanese population. Invest Ophthalmol Vis Sc201253794–8
42.
ChuJZhouCCLuNZhangXDongFTGenetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population. Chin Med20081212525–33
43.
EdwardsAOFridleyBLJamesKMSharmaAKCunninghamJMTosakulwongNEvaluation of clustering and genotype distribution for replication in genome wide association studies: the age-related eye disease study [erratum in 2008; 3.doi.org/10.1371/annotation/34c41e76-e7dc-4a84-b1b7-c3f895207d9f]. PLoS On20083e3813
44.
ChanockSJManolioTBoehnkeMNCI-NHGRI Working Group on Replication in Association Studies. Replicating genotype-phenotype associations. Natur2007447655–60
